{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:50:41Z","timestamp":1783612241588,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/fpc.0000000000000345","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:11:29Z","timestamp":1534464689000},"page":"189-195","source":"Crossref","is-referenced-by-count":32,"title":["Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia"],"prefix":"10.1097","volume":"28","author":[{"given":"Nathalie K.","family":"Zgheib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Aridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Shahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidale","family":"Tarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel R.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"El-Solh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar A.","family":"Muwakkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210213","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute Lymphoblastic Leukemia in Children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MPH.0b013e3181868570","article-title":"Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia","volume":"30","author":"Davidsen","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J Clin Oncol"},{"key":"R5-1-20210213","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/FPC.0000000000000069","article-title":"Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia","volume":"24","author":"Zgheib","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/pbc.26189","article-title":"NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children\u2019s Cancer Center of Lebanon","volume":"64","author":"Zgheib","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R7-1-20210213","first-page":"2416","article-title":"Vincristine-induced peripheral neuropathy in pediatric cancer patients","volume":"6","author":"Mora","year":"2016","journal-title":"Am J Cancer Res"},{"key":"R8-1-20210213","first-page":"269","article-title":"Pharmacokinetics and metabolism of vinca alkaloids","volume":"17","author":"Rahmani","year":"1993","journal-title":"Cancer Surv"},{"key":"R9-1-20210213","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/pbc.22161","article-title":"Vincristine: can its therapeutic index be enhanced?","volume":"53","author":"Moore","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R10-1-20210213","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pbc.21435","article-title":"Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients","volume":"50","author":"Renbarger","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R11-1-20210213","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/dmd.106.009902","article-title":"Selective metabolism of vincristine in vitro by CYP3A5","volume":"34","author":"Dennison","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0006-2952(93)90169-W","article-title":"Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions","volume":"45","author":"Zhou","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R13-1-20210213","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1158\/0008-5472.CAN-08-1420","article-title":"Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B","volume":"69","author":"Hopper-Borge","year":"2009","journal-title":"Cancer Res"},{"key":"R14-1-20210213","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.bcp.2006.03.009","article-title":"Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines","volume":"71","author":"Huang","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"R15-1-20210213","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clpt.2004.05.007","article-title":"Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia","volume":"76","author":"Plasschaert","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R16-1-20210213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.leukres.2009.04.027","article-title":"Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia","volume":"34","author":"Hartman","year":"2010","journal-title":"Leuk Res"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22845","article-title":"Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia","volume":"56","author":"Egbelakin","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R18-1-20210213","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/pgs.14.68","article-title":"Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia","volume":"15","author":"Ceppi","year":"2014","journal-title":"Pharmacogenomics"},{"key":"R19-1-20210213","first-page":"509","article-title":"Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia","volume":"23","author":"Efferth","year":"2003","journal-title":"Int J Oncol"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/pgs-2016-0001","article-title":"Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia","volume":"17","author":"Lopez-Lopez","year":"2016","journal-title":"Pharmacogenomics"},{"key":"R21-1-20210213","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2015.0894","article-title":"Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"313","author":"Diouf","year":"2015","journal-title":"JAMA"},{"key":"R22-1-20210213","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ajh.23222","article-title":"Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon","volume":"87","author":"Muwakkit","year":"2012","journal-title":"Am J Hematol"},{"key":"R24-1-20210213","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/FPC.0000000000000191","article-title":"Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population","volume":"26","author":"Gutierrez-Camino","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"R25-1-20210213","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/FPC.0000000000000192","article-title":"Vincristine pharmacogenomics: \u2018winner\u2019s curse\u2019 or a different phenotype?","volume":"26","author":"Diouf","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"R26-1-20210213","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3322\/caac.21204","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"R27-1-20210213","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jps.20717","article-title":"MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells","volume":"95","author":"Salama","year":"2006","journal-title":"J Pharm Sci"},{"key":"R28-1-20210213","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cpt.506","article-title":"An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia","volume":"101","author":"Stock","year":"2017","journal-title":"Clin Pharmacol Ther"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:24:26Z","timestamp":1620951866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201808000-00001"}},"subtitle":["a single institution study"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000345","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}